Table 1.
Disorder | Gene (if known) | IgG replacement indicated? |
---|---|---|
Agammaglobulinemia | ||
X-linked agammaglobulinemia | Btk | Yes |
μ heavy chain deficiency | IGHM | Yes |
Igα deficiency | CD79A | Yes |
Igβ deficiency | CD79B | Yes |
B-cell linker protein | BLNK | Yes |
Common variable immune deficiency | ||
Immune co-stimulator protein | ICOS | Yes |
CD19 deficiency | CD19 | Yes |
CD20 deficiency | CD20 | Yes |
TACI deficiency | TNFRSF13B | Yes |
BAFF receptor deficiency | TNFRSF13C | Yes |
CVID | Unknown | Yes |
Other antibody deficiencies | ||
Selective IgA deficiency | Unknown | No |
IgG subclass deficiency | Unknown | If recurrent infections |
Specific antibody deficiency | Unknown | |
Transient hypogammaglobulinemia of infancy | Unknown | |
Other PIDD with antibody deficiency | ||
HyperIgM syndrome X-linked | CD40L | Yes |
Autosomal recessive | AID, UNG | Yes |
Severe combined immune deficiency | Various | Yes |
Wiskott–Aldrich syndrome | WASP | Yes |
Ataxia-telangiectasia syndrome | ATM | Yes |
Reticular dysgenesis | AK2 | Yes |
DiGeorge syndrome | 22q11.2/10p13 deletion | Only for patients with low IgG |
Note: Data based on IUIS classification of primary immune deficiencies.1
Abbreviations: IgG, immunoglobulin G; Btk, Bruton’s tyrosine kinase; TACI, transmembrane activator and calcium-modulating cyclophilin ligand interactor; TNFRSF, tumor necrosis factor receptor super family; BAFF, B-cell activating factor; CVID, common variable immune deficiency; CD40L, CD40 ligand; AID, activating inducing cytidine deaminase; UNG, uracil DNA glycosylase; WASP, Wiskott–Aldrich syndrome protein; ATM, ataxia-telangiectasia mutated; AK2, adenylate kinase 2.